These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23734323)

  • 1. Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting.
    Birklé S; Desselle A; Chaumette T; Gaugler MH; Cochonneau D; Fleurence J; Dubois N; Hulin P; Aubry J; Paris F
    Oncoimmunology; 2013 Apr; 2(4):e23700. PubMed ID: 23734323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.
    Desselle A; Chaumette T; Gaugler MH; Cochonneau D; Fleurence J; Dubois N; Hulin P; Aubry J; Birklé S; Paris F
    PLoS One; 2012; 7(11):e45423. PubMed ID: 23189121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, promoter-based, target-specific assay identifies 2-deoxy-D-glucose as an inhibitor of globotriaosylceramide biosynthesis.
    Okuda T; Furukawa K; Nakayama K
    FEBS J; 2009 Sep; 276(18):5191-202. PubMed ID: 19674101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.
    Valbuena C; Leitão D; Carneiro F; Oliveira JP
    Virchows Arch; 2012 Feb; 460(2):211-21. PubMed ID: 22205110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance.
    Zarrin B; Zarifi F; Vaseghi G; Javanmard SH
    J Res Med Sci; 2017; 22():117. PubMed ID: 29184575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Diversities of Lectins Binding to the Glycosphingolipid Gb3.
    Siukstaite L; Imberty A; Römer W
    Front Mol Biosci; 2021; 8():704685. PubMed ID: 34381814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression.
    Shin IS; Ishii S; Shin JS; Sung KI; Park BS; Jang HY; Kim BW
    BMB Rep; 2009 May; 42(5):310-4. PubMed ID: 19470247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
    Wilson PM; LaBonte MJ; Lenz HJ
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
    Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of glycosphingolipid receptors for pierisin-1, a guanine-specific ADP-ribosylating toxin from the cabbage butterfly.
    Matsushima-Hibiya Y; Watanabe M; Hidari KI; Miyamoto D; Suzuki Y; Kasama T; Kasama T; Koyama K; Sugimura T; Wakabayashi K
    J Biol Chem; 2003 Mar; 278(11):9972-8. PubMed ID: 12645583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.
    Kamani MA; Provençal P; Boutin M; Pacienza N; Fan X; Novak A; Huang TC; Binnington B; Au BC; Auray-Blais C; Lingwood CA; Medin JA
    Future Sci OA; 2016 Dec; 2(4):FSO147. PubMed ID: 28116130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Vero cell cytotoxic activity in Escherichia coli O157:H7 lysates by globotriaosylceramide, Gb3, from bovine milk.
    Watarai S; Tana ; Inoue K; Kushi Y; Isogai E; Yokota K; Naka K; Oguma K; Kodama H
    Biosci Biotechnol Biochem; 2001 Feb; 65(2):414-9. PubMed ID: 11302178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM; Lingwood CA
    Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of globotriaosylceramide tail saturation level on bilayer phases.
    Pezeshkian W; Chaban VV; Johannes L; Shillcock J; Ipsen JH; Khandelia H
    Soft Matter; 2015 Feb; 11(7):1352-61. PubMed ID: 25575293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive accumulation of globotriaosylceramide in various tissues from a Fabry patient with a high antibody titer against alpha-galactosidase A after 6 years of enzyme replacement therapy.
    Hongo K; Harada T; Fukuro E; Kobayashi M; Ohashi T; Eto Y
    Mol Genet Metab Rep; 2020 Sep; 24():100623. PubMed ID: 32714835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy.
    Behnam-Motlagh P; Tyler A; Grankvist K; Johansson A
    Toxins (Basel); 2010 Oct; 2(10):2467-77. PubMed ID: 22069561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
    Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP
    Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globotriaosylceramide-expressing Burkitt's lymphoma cells are committed to early apoptotic status by rhamnose-binding lectin from catfish eggs.
    Kawano T; Sugawara S; Hosono M; Tatsuta T; Ogawa Y; Fujimura T; Taka H; Murayama K; Nitta K
    Biol Pharm Bull; 2009 Mar; 32(3):345-53. PubMed ID: 19252276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
    Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
    Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules.
    Pircher A; Wellbrock J; Fiedler W; Heidegger I; Gunsilius E; Hilbe W
    Oncology; 2014; 86(1):46-52. PubMed ID: 24401553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.